Literature DB >> 10799896

Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-beta and IL-4.

I O Farah1, P W Mola, T M Kariuki, M Nyindo, R E Blanton, C L King.   

Abstract

Recently, we observed that repeated Schistosoma mansoni infection and treatment boost Th2-associated cytokines and TGF-beta production in baboons. Other studies have shown that some chronically infected baboons develop hepatic fibrosis. Because TGF-beta, IL-2, and IL-4 have been shown to participate in development of fibrosis in murine schistosomiasis, the present study examined whether repeated exposure stimulates hepatic fibrosis in olive baboons. To test this hypothesis, animals were exposed to similar numbers of S. mansoni cercariae given once or repeatedly. After 19 wk of infection, animals were cured with praziquantel and reinfected once or multiple times. Hepatic granulomatous inflammation and fibrosis were assessed from serial liver biopsies taken at weeks 6, 9, and 16 after reinfection and egg Ag (schistosome egg Ag)-specific cytokine production by PBMC were measured simultaneously. Periportal fibroblast infiltration and extracellular matrix deposition (fibrosis), angiogenesis, and biliary duct hyperplasia developed in some animals. The presence and amount of fibrosis directly correlated with the frequency of exposure. Fibrosis was not associated with adult worm or tissue egg burden. The amount of fibrosis correlated with increased schistosome egg Ag-driven TGF-beta at 6, 9, and 16 wk postinfection (rs = 0.9, 0.8, and 0.54, respectively, all p < 0.01) and IL-4 production (p = 0.02) at 16 wk postinfection and not IFN-gamma, IL-2, IL-5, or IL-10. These data suggest that repeated exposure is a risk factor for periportal fibrosis by a mechanism that primes lymphocytes to produce increased levels of profibrotic molecules that include TGF-beta and IL-4.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799896     DOI: 10.4049/jimmunol.164.10.5337

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Migration of splenic lymphocytes promotes liver fibrosis through modification of T helper cytokine balance in mice.

Authors:  Kazutaka Tanabe; Kojiro Taura; Yukinori Koyama; Gen Yamamoto; Takahiro Nishio; Yukihiro Okuda; Kojiro Nakamura; Kan Toriguchi; Kenji Takemoto; Kenya Yamanaka; Keiko Iwaisako; Satoru Seo; Masataka Asagiri; Etsuro Hatano; Shinji Uemoto
Journal:  J Gastroenterol       Date:  2015-02-28       Impact factor: 7.527

2.  Dexamethasone, a drug for attenuation of Schistosoma mansoni infection morbidity.

Authors:  Alexandre dos Santos Pyrrho; Juliene Antonio Ramos; Roberto Moura Neto; Célia Santos da Silva; Henrique Leonel Lenzi; Christina Maeda Takiya; Cerli Rocha Gattass
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

3.  Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans.

Authors:  L F Alves Oliveira; E C Moreno; G Gazzinelli; O A Martins-Filho; A M S Silveira; A Gazzinelli; L C C Malaquias; P LoVerde; P Martins Leite; R Correa-Oliveira
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

Review 4.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis.

Authors:  De'Broski R Herbert; Tatyana Orekov; Charles Perkins; Fred D Finkelman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

6.  Hepatic stellate cells and parasite-induced liver fibrosis.

Authors:  Barrie Anthony; Jeremy T Allen; Yuesheng S Li; Donald P McManus
Journal:  Parasit Vectors       Date:  2010-07-21       Impact factor: 3.876

7.  Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response.

Authors:  Mahasen Abdel-Rahman; Mohammad El-Sayed; Maissa El Raziky; Aisha Elsharkawy; Wafaa El-Akel; Hossam Ghoneim; Hany Khattab; Gamal Esmat
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

Review 8.  Mononuclear cells in liver fibrosis.

Authors:  Fabio Marra; Sara Aleffi; Sara Galastri; Angela Provenzano
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

9.  Effect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni.

Authors:  P Martins-Leite; G Gazzinelli; L F Alves-Oliveira; A Gazzinelli; L C C Malaquias; R Correa-Oliveira; A Teixeira-Carvalho; A M S Silveira
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

10.  Protective Effect of Chronic Schistosomiasis in Baboons Coinfected with Schistosoma mansoni and Plasmodium knowlesi.

Authors:  Ruth K Nyakundi; Onkoba Nyamongo; Jeneby Maamun; Mercy Akinyi; Isaac Mulei; Idle O Farah; D'Arbra Blankenship; Brian Grimberg; Jann Hau; Indu Malhotra; Hastings Ozwara; Christopher L King; Thomas M Kariuki
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.